Tarsus Pharmaceuticals Stock Forecast

Sell candidate since Jul 29, 2026

The Tarsus Pharmaceuticals, Inc. stock price fell by -0.729% on the last day (Wednesday, 29th Jul 2026) from $58.95 to $58.52. During the last trading day the stock fluctuated 3.61% from a day low at $57.33 to a day high of $59.40. The price has risen in 7 of the last 10 days and is up by 1.77% over the past 2 weeks. Volume has increased on the last day by 180 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 680 thousand shares were bought and sold for approximately $39.77 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -4.46% during the next 3 months and, with a 90% probability hold a price between $52.87 and $66.59 at the end of this 3-month period.

TARS Signals & Forecast

There are few to no technical positive signals at the moment. The Tarsus Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $58.52 and $61.55. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, July 27, 2026, and so far it has fallen -2.66%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Tarsus Pharmaceuticals, Inc. stock

Tarsus Pharmaceuticals, Inc. finds support from accumulated volume at $58.14 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.07 between high and low, or 3.61%. For the last week, the stock has had daily average volatility of 3.79%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TARS) For The Upcoming Trading Day Of Thursday 30th

For the upcoming trading day on Thursday, 30th we expect Tarsus Pharmaceuticals, Inc. to open at $58.42, and during the day (based on 14 day Average True Range), to move between $56.93 and $60.11, which gives a possible trading interval of +/-$3.18 (+/-5.59%) up or down from last closing price. If Tarsus Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 5.59% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $58.14 (0.65%) than the resistance at $60.89 (4.05%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Tarsus Pharmaceuticals, Inc. stock A Buy?

Tarsus Pharmaceuticals, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -3.067 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 30, 2026 - $58.42 ( 0.177%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk